BML Inc.

Financial Results

Presentation for Fiscal 2020

May 13, 2021

Kensuke Kondo,

President and

Representative Director

Overview of Fiscal 2020

Financial Results

2

10-Year Earnings History

Novel coronavirus PCR tests contributing to increases in both

sales and income

(Millions of yen)

FY2020

3

Year-on-Year Comparison

(Millions of yen)

FY2019

FY2020

Year on

Change

year

Net sales

120,732

138,571

17,839

14.8%

Testing business

115,022

132,911

17,888

15.6%

Clinical testing business

110,113

128,612

18,498

16.8%

Other testing business

4,908

4,299

(609)

(12.4)%

Medical informatics business

4,202

4,214

12

0.3%

Other businesses

1,507

1,445

(61)

(4.1)%

Operating income

9,763

19,936

10,172

104.2%

Ordinary income

10,211

20,803

10,592

103.7%

Profit attributable to owners of

6,375

13,711

7,336

115.1%

parent

4

Breakdown of Changes in Sales by Business Segment

Net sales up ¥17,839m (14.8%) YoY

(Millions of yen)

609

49

138,571

18,498

Food hygiene

Medical

business, etc.

informatics

+17,839

business,

Clinical testing

other businesses

business

120,732

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

BML Inc. published this content on 13 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 June 2021 00:24:00 UTC.